(U.S.) FDA recommends against using screening tests for ovarian cancer screening Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, September 09, 2016

(U.S.) FDA recommends against using screening tests for ovarian cancer screening



Safety Communications > The FDA recommends against using screening tests for ovarian cancer screening: FDA Safety Communication


Summary of Problem and Scope:

Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results. However, over the years, numerous companies have marketed tests that claim to screen for and detect ovarian cancer.
For example, recently, Abcodia Incorporated began marketing the Risk of Ovarian Cancer Algorithm (ROCA) test in the United States, with claims that the ROCA test can screen for and detect ovarian cancer before symptoms appear and increase the chance for survival. Yet, available data do not support its claims......

0 comments :

Post a Comment

Your comments?